Mycenax Biotech Inc. (4726)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
24. 55
0
0%
NT$
- Market Cap
- P/E Ratio
- Div Yield
28,814 Volume
- Eps
NT$ 24.55
Previous Close Want to track 4726 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mycenax Biotech Inc. (4726) Statistics
Valuation metrics
Market Cap -
Enterprise value 6.01B
Trailing P/E (ttm) -11.54
Forward P/E -
PEG ratio -2.87
Price/Sales (ttm) 6.18
Price/Book (mrq) 3.42
Enterprise Value/Revenue 7.37
Enterprise Value/EBITDA -31.79
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 133.9K
Average volume (90 days) 232.31K
Price summary
52-Week low 23.95
52-Week high 40
Beta -
50-Day moving average 25
200-Day moving average 28.97
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,163:1,000
Last split Date 17 Dec 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.54%
Operating margin -0.47%
Operational effectiveness
Return on assets -0.13%
Return on equity -0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.9
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.09
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.04
Total debt (mrq) -
Total Debt/Equity (mrq) 0.8
Current ratio (mrq) 0.5%
Book value per share (mrq) 7.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
